Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
1.410
-0.010 (-0.70%)
Jul 2, 2024, 3:55 PM EDT - Market closed
Agile Therapeutics Market Cap
Agile Therapeutics has a market cap or net worth of $9.67 million as of July 2, 2024. Its market cap has increased by 13.73% in one year.
Market Cap
9.67M
Enterprise Value
7.43M
1-Year Change
13.73%
Ranking
n/a
Category
Stock Price
$1.41
Market Cap Chart
Since May 23, 2014, Agile Therapeutics's market cap has decreased from $50.00M to $9.67M, a decrease of -80.67%. That is a compound annual growth rate of -15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2024 | 1.50M | -69.39% |
| Dec 29, 2023 | 4.90M | -46.74% |
| Dec 30, 2022 | 9.20M | -84.49% |
| Dec 31, 2021 | 59.30M | -76.37% |
| Dec 31, 2020 | 250.90M | 69.18% |
| Dec 31, 2019 | 148.30M | 648.99% |
| Dec 31, 2018 | 19.80M | -78.48% |
| Dec 29, 2017 | 92.00M | -43.87% |
| Dec 30, 2016 | 163.90M | -24.68% |
| Dec 31, 2015 | 217.60M | 90.54% |
| Dec 31, 2014 | 114.20M | 128.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.38B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |